Lipoxen is enabling a new generation of medicines with its delivery technologies for protein drugs, anti-cancer drugs and vaccines, delivering drugs with enhanced efficacy and fewer side effects.Lipoxen’s technologies improve the performance of existing drugs, while enabling the development of new drugs with a reduced risk of failure in development due to lack of efficacy or toxicity.Lipoxen works in partnership in the research and development of products to treat or prevent important diseases such as cancer, diabetes and infectious diseases such as pneumonia in infants with the following companies: Amgen, Genentec Baxter, Genzyme, The Poonawalla Group and The Serum Institute of India
www.lipoxen.com